71th-Cardio-Website_EN-Mob

Satellite Sessions

June 3 , 2024

AstraZeneca | 07:00-08:00

Title: TTRansforming Care in Amyloidosis

 Session Agenda: TBD

Bayer + AstraZeneca | 12:30-14:00

Title: Heart and Kidney in Harmony: The Game-Changing Potential of SGLT21 & ns-MRA

 Session Agenda: TBD

Medison Pharma | 12:30-14:00

Title: The Optical Illusion of the PCSK9 Treatment: You Can Get Much More Than What You See

Click here to view agenda.

Pfizer Pharmaceuticals Israel | 12:30-14:00

Title: Can We Do BeTTR? Optimizing diagnosis of Cardiac Amyloidosis in Herat Failure Patients

 
Session is open for medical technicians

Session Agenda: TBD

Abbott Laboratories | 12:30-14:00

Title: When Experience Matters Most – Mitral & TriCuspid Interventions

Session Agenda: TBD

Novo Nordisk | 12:30-14:00

Title: Navigating Residual Risk in T2D- Innovative Strategies for Improved Outcomes

Click here to view agenda.

June 4 , 2024

Medtechnica | 12:30-14:00

Title: Intra Coronary Imaging: Expanding Hirisings to Improve Outcomes

 Session Agenda: TBD

Novo Nordisk | 12:30-14:00

Title: Mending broken hearts with GLP-1 in obesity management

Click here to view agenda.

Boehringer Ingelheim Israel | 12:30-14:00

Title: International latest’s updates in Treatment for Heart Failure

Click here to view agenda.

Pfizer | 12:30-14:00

Title: Navigating Cardiac Amyloidosis: Echocardiography and Differential Diagnosis in Focus

Session Agenda: TBD

Novartis Israel | 12:30-14:00

Title: Heart Frontiers: Today’s Lipid Innovations, Tomorrow’s Standards

Click here to view agenda.

Edwards Lifesciences | 12:30-14:00

Title: Latest Technology Updates and Key Considerations Regarding Valve Therapy

Session Agenda: TBD